Kelly Shi
Stock Analyst at Jefferies
(2.24)
# 2,678
Out of 4,944 analysts
32
Total ratings
44.83%
Success rate
-0.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $129 → $148 | $122.00 | +21.31% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $11.56 | +142.32% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $25.69 | +71.31% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $8.21 | +82.70% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $26.83 | +93.81% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.87 | +187.47% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $17.15 | +10.79% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $196.02 | -0.01% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $2.47 | +750.20% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $12.97 | +185.27% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.24 | +167.86% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $45.27 | +1.61% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $81.61 | -0.75% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $16.95 | +106.49% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.33 | +2,606.77% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $54.84 | -70.82% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $39.87 | +0.33% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.45 | +349.44% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.47 | +223.89% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.64 | +4,125.35% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $15.26 | +240.76% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.27 | +1,089.43% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.91 | +1,627.75% | 1 | Mar 8, 2021 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $122.00
Upside: +21.31%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $11.56
Upside: +142.32%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $25.69
Upside: +71.31%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $8.21
Upside: +82.70%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $26.83
Upside: +93.81%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.87
Upside: +187.47%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $17.15
Upside: +10.79%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $196.02
Upside: -0.01%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $2.47
Upside: +750.20%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $12.97
Upside: +185.27%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.24
Upside: +167.86%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $45.27
Upside: +1.61%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $81.61
Upside: -0.75%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $16.95
Upside: +106.49%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.33
Upside: +2,606.77%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $54.84
Upside: -70.82%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $39.87
Upside: +0.33%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $4.45
Upside: +349.44%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.47
Upside: +223.89%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.64
Upside: +4,125.35%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $15.26
Upside: +240.76%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.27
Upside: +1,089.43%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.91
Upside: +1,627.75%